George Medicines' recently-approved high blood pressure therapy Widaplik could offer a desperately needed new treatment for ...

Johnny Cheng, currently CFO of HUTCHMED, has been named acting CEO following the departure of Dr Weiguo Su due to health ...

Pharma has three choices when it comes to AI for patient experience: Resist it. Try to control patient-led innovation through ...

The immediate consequences of the disappointing result are a big reduction in workforce at South San Francisco-based Alector, ...

Moderna has decided to halt the development of its mRNA-1647 vaccine for congenital cytomegalovirus (CMV) infections – once ...

Google says it has made a breakthrough in its quantum computing research with an algorithm that can run calculations 13,000 ...

GSK and Spero Therapeutics' oral cabapenem, tebipenem HBr, has become the first antibiotic in the class to show efficacy in a ...

Alkermes has reached an agreement to buy Avadel Pharma in a deal valued at up to $2.1 billion, claiming rights to an ...

Merck KGaA has become the third pharma company to reach an agreement with the Trump administration to cut the cost of some of ...

Novo Nordisk's chairman Helge Lund and several other independent board members have indicated they will step down next month, ...

The company ended the first half of this year with €3.1 billion ($3.6 billion) in cash reserves, and is due to report its ...

Amgen and AstraZeneca's Tezspire has claimed FDA approval as a treatment for chronic rhinosinusitis with nasal polyps (CRSwNP ...